Sustained Therapeutics Advances Non-Opioid Pain Management with Promising Phase 2 Trial Results Sustained Therapeutics announces encouraging Phase 2 results for ST-01, a long-acting non-opioid medication aimed at chronic pain treatment, paving the way for Phase 3 trials.

Sustained Therapeutics Advances Non-Opioid Pain Management with Promising Phase 2 Trial Results #Canada #Vancouver #Chronic_Pain #Sustained_Therapeutics #ST-01